Skip to main content

Bank of New York Mellon Corp

Bank

Position in BBIO — BridgeBio Pharma, Inc.

CIK 1390777 NEW YORK, NY

Position in BBIO

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$42,869,031
-$2,749,828 QoQ
Shares Held
577,283
-3.2% QoQ
Ownership
0.295%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 91% Shared 0% None 9%

Common Shares in BBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Bank of New York Mellon Corp holds $4,203,063,863 across 270 Biotechnology names. BBIO ranks #20 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BBIO

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $42,869,031 577,283
2025-12-31 $45,618,859 596,403
2025-09-30 $48,188,522 927,773
2025-06-30 $23,671,574 548,207
2025-03-31 $16,720,642 483,675
2024-12-31 $13,751,031 501,131
2024-09-30 $12,935,459 508,070
2024-06-30 $15,825,395 624,769
2024-03-31 $15,833,849 512,091
2023-12-31 $21,962,042 544,019
2023-09-30 $12,229,795 463,777
2023-06-30 $8,071,442 469,270
2023-03-31 $7,772,634 468,796
2022-12-31 $3,315,933 435,162
2022-09-30 $4,273,304 429,910
2022-06-30 $3,418,011 376,433
2022-03-31 $5,102,535 502,713
2021-12-31 $8,128,914 487,345
2021-09-30 $22,249,374 474,704
2021-06-30 $27,620,730 453,096
2021-03-31 $22,692,760 368,389
2020-09-30 $9,302,557 247,936
2020-06-30 $7,546,017 231,402
2020-03-31 $6,509,050 224,450